|

Colchicine 0.5 MG Oral Tablet Once Daily Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since July 2026

Also known as: Lodoco

Pipeline

Phase 3: 1

Top Sponsors

  • Shanghai Tongji Hospital, Tongji University School of Medicine1
  • Duke University1

Indications

  • Heart Disease2
  • Prevention & Control1
  • Coronary Artery Disease Risk Factors Multiple1
  • Premature Atherosclerosis1
  • Coronary Artery Disease Progression1

Other1 trial

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients
N/A

Birmingham, Alabama1 trial

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

University of Alabama at Birmingham

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.